Biopsied tumor samples were subjected to immunohistochemical (IHC) staining (with Caspase-3, which appears brown) and general hematoxylin–eosin (H&E) staining to verify the treatment’s efficiency. The gene discussed is CASP3; the disease is neoplasm.